GlassScriptPhysician profile
Kevin L Kirk
NPI 1316910490
$11,232.82
in general payments reported to CMS, 2019-2025
16 companies · $203 in 2025
The $203 reported for 2025 was less than what a typical Foot and Ankle Surgery provider received nationally (typical 2025 total: $1,200).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $7,950 · 2020: $119 · 2021: $1,938 · 2022: $442 · 2023: $372 · 2024: $208 · 2025: $203.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $782.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $782.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $3,070.72 | 2019-2025 | Augment Injectable, Axsos, Fixos |
| Synthes USA Products LLC | $2,925.00 | 2019 | |
| Radius Health, INC. | $2,056.08 | 2019-2022 | |
| Wright Medical Technology, INC. | $1,115.96 | 2019 | |
| Gemini Medical LLC | $1,002.00 | 2019 | |
| Medinc of Texas | $495.07 | 2019 | |
| Depuy Synthes Sales INC. | $158.57 | 2019-2022 | |
| Pacira Pharmaceuticals Incorporated | $153.41 | 2019-2022 | |
| Amgen INC. | $116.67 | 2024 | Prolia, Evenity |
| Abbvie INC. | $30.03 | 2024 | |
| Abbott Laboratories | $28.86 | 2019 | |
| Orthofix Medical, INC. | $23.63 | 2019-2020 | |
| Ferring Pharmaceuticals INC. | $15.86 | 2019 | |
| Horizon Therapeutics Plc | $13.83 | 2019 | |
| Kerecis Limited | $13.77 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $13.36 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kevin Kirk listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.